Checkpoint Surgical will add 18 new jobs at its Highland Hills headquarters after being awarded an Ohio Job Creation Tax Credit (TCA) totaling $200,000.
The addition of the new jobs, doubling the size of its Ohio-based team, comes with additional payroll of $1.9 million on top of its current 17 employees and nearly $2.3 million in payroll.
The new jobs at Checkpoint, which produces neuro-stimulation medical devices, will be in engineering, technical support, sales and marketing.
"This support is critical to managing the high costs associated with scaling a medical device company in a highly competitive worldwide market," Len Cosentino, president and CEO of Checkpoint Surgical, said in a statement.
Checkpoint received FDA Breakthrough Device Designation in 2019 for its brief electrostimulation therapy (BEST), a device designed to promote regeneration in nerve-injury surgical procedures. The Breakthrough designation is intended to expedite development of therapies that demonstrate substantial improvements for serious conditions.
In 2018, Checkpoint completed an $8.8 million equity financing round led by Mutual Capital Partners intended to grow the company's sales and marketing departments, develop new market opportunities and build out a research-and-development team. Chicago-based First Analysis, JumpStart NEXT Fund and individual investors also contributed to that funding.
Read more about the company's growth here